Streetbeat News

Revenues

SPY

USA Personal Spending for October showed a 0.2% increase, aligning with the 0.2% estimate and showing a decrease from the 0.7% increase in the prior month.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:31 pm

ASO

Academy Sports (ASO) has updated its FY23 net sales forecast, narrowing the range from $6.175B-$6.365B to $6.110B-$6.170B, which is below the consensus estimate of $6.23B. The company also revised its adjusted EPS outlook, raising the lower end of the range from $6.95-$7.65 to $7.05-$7.20, compared to the estimate of $7.13.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:17 pm

BIAF

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW) announced CMS' final payment determination for CyPath Lung, a noninvasive lung cancer test, effective January 2024. This facilitates reimbursement by Medicare and private payers, aiding commercialization. The AMA issued CPT code 0406U for CyPath Lung in June 2023, with CMS finalizing payment in November 2023. CyPath Lung uses flow cytometry and AI for early-stage lung cancer detection, showing high sensitivity and specificity in clinical trials.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:11 pm

GH

Guardant Health will present data at the San Antonio Breast Cancer Symposium showing the effectiveness of its liquid biopsy tests in biomarker identification, therapy selection, and detection of minimal residual disease (MRD). The studies highlight the Guardant Reveal™ test's ability to prognosticate distant cancer recurrence nearly eight months earlier than standard care methods.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:09 pm

SATX

SatixFy Communications reported a 31% year-over-year increase in revenues, totaling $8.9 million for the nine months ended September 30, 2023. Gross profit reached $4.5 million, representing a gross margin of 50.8% and a 21% increase from the previous year's $3.7 million.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:09 pm

CDTX

Cidara Therapeutics, Inc. (NASDAQ:CDTX) will present new preclinical data on its novel drug-Fc conjugate (DFC) immunotherapies at the ESMO Immuno-Oncology Congress. The presentations will cover a dual-acting CD73/PD-1 targeting DFC candidate and CBO421, a first-in-class CD73 targeting DFC. The event is scheduled for December 6-8, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:08 pm

AERT

Aeries Technology (NASDAQ:AERT) reported a 37.50% increase in Q2 sales to $17.60 million, up from $12.80 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:06 pm

CBRL

Cracker Barrel anticipates its FY24 total revenue to be between $3.4 billion and $3.5 billion, which aligns with the estimated revenue of $3.5 billion.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:06 pm

BOSC

BOS Better Online Solutions (BOSC) reported Q3 earnings of $0.05 per share, consistent with the same period last year. Sales increased by 8.51% to $9.81M from $9.04M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:05 pm

CBRL

Cracker Barrel reported a decrease in Q1 comparable store restaurant sales by 0.5% and a more significant drop in comparable store retail sales by 8.1%.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 1:03 pm